Multiple Companies Face Class Action Lawsuit Reminder
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 31 2026
0mins
Should l Buy VITL?
Source: Globenewswire
- Atara Biotherapeutics Lawsuit: A class action lawsuit against Atara Biotherapeutics, Inc. alleges that from May 20, 2024, to January 9, 2026, the company failed to disclose critical facts regarding its manufacturing and tabelecleucel's regulatory prospects, leading to significant investor losses, with a deadline of May 22, 2026, to apply as lead plaintiff.
- Coty's Fragrance Segment Issues: Coty Inc. is facing a class action lawsuit alleging that between November 5, 2025, and February 4, 2026, it failed to disclose material facts about slowing growth in its Prestige fragrance segment, prompting affected investors to seek lead plaintiff status by May 22, 2026.
- Vital Farms ERP Implementation Dispute: The class action lawsuit against Vital Farms, Inc. claims that from May 8, 2025, to February 26, 2026, the company did not disclose important facts regarding the implementation of its new enterprise resource planning system, with a lead plaintiff application deadline of May 26, 2026.
- Super Micro Compliance Issues: Super Micro Computer, Inc. is involved in a class action lawsuit alleging non-compliance with export control laws from April 30, 2024, to March 19, 2026, with investors needing to apply for lead plaintiff status by May 26, 2026, if they suffered losses during this period.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy VITL?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on VITL
Wall Street analysts forecast VITL stock price to rise
12 Analyst Rating
11 Buy
0 Hold
1 Sell
Strong Buy
Current: 12.770
Low
44.00
Averages
48.90
High
60.00
Current: 12.770
Low
44.00
Averages
48.90
High
60.00
About VITL
Vital Farms, Inc. offers a range of ethically produced foods nationwide. The Company is a national consumer brand that works with more than 575 family farms and is the United States brand of pasture-raised eggs. The Company focuses on the humane treatment of farm animals and sustainable farming practices. The Company packages, markets and distributes shell eggs, butter, and other products. Its products, including shell eggs, butter, hard-boiled eggs, and liquid whole eggs, are sold in approximately 23,500 stores nationwide. The retail varieties of its shell eggs are based on supplemental feed type, egg size, and pack size. Its egg packaging consists primarily of corrugated boxes and egg cartons. The Company offers unsalted and sea-salted varieties of its butter, which are sold in two-stick and four-stick packs. The Company’s products are principally sold under the name Vital Farms in addition to other trade names, primarily to retail and foodservice channels in the United States.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Class Action Deadline: The lead plaintiff deadline for the Vital Farms securities class action is May 26, 2026, urging investors who purchased securities between May 8, 2025, and February 26, 2026, to participate in the lawsuit to protect their rights.
- Lawsuit Background: The lawsuit alleges that Vital Farms downplayed the risks associated with delays in rolling out its new ERP system, resulting in missed full-year 2025 earnings guidance and consensus EPS, causing investor losses when the truth emerged.
- Law Firm Credentials: The Rosen Law Firm specializes in securities class actions and recovered over $438 million for investors in 2019 alone, being ranked first by ISS Securities Class Action Services in 2017, showcasing its strong capabilities and successful track record in this field.
- Participation Instructions: Investors can visit the Rosen Law Firm's website or call toll-free at 866-767-3653 for more information on joining the class action, ensuring their rights to potential future recoveries are secured.
See More
- Class Action Filed: Wolf Haldenstein Adler Freeman & Herz LLP has announced a class action lawsuit on behalf of investors who purchased Vital Farms securities between May 8, 2025, and February 26, 2026, with a deadline of May 26, 2026, for investors to apply as lead plaintiffs, indicating significant investor dissatisfaction with the company's financial performance.
- Earnings Miss: The annual report filed on February 26, 2026, revealed that Vital Farms generated $759.44 million in revenue for fiscal year 2025, falling short of the $775 million guidance, while the reported earnings per share (EPS) of $0.35 also missed the consensus estimate of $0.39, highlighting challenges in financial management.
- ERP System Disruptions: The 10-K report noted temporary disruptions in order and fulfillment levels following the launch of a new ERP system, which likely contributed to the revenue and earnings shortfall, exacerbating investor concerns about operational efficiency.
- Stock Price Decline: Following the earnings report, Vital Farms' stock price dropped by $2.68, or approximately 11%, from $24.79 on February 25, 2026, to close at $22.11 on February 26, reflecting a pessimistic outlook from the market regarding the company's future performance.
See More
- Downgrade Impact: TD Cowen downgraded Vital Farms from Buy to Hold and slashed the price target by 36% to $16 per share, causing the stock to spend nearly the entire day in negative territory, reflecting market concerns about the company's future performance.
- Sales Trend Slowdown: The analyst noted that the slowdown in VITL's retail sales trends has already led to a contraction in the stock's valuation multiple, while elevated short interest indicates investor caution regarding the company's outlook.
- Divergent Market Sentiment: While Wall Street remains mostly bullish on Vital Farms, viewing it as a Strong Buy, Seeking Alpha's Quant score gives it a low rating of 1.09, indicating significant weaknesses in momentum and revisions, highlighting market disagreement on its growth prospects.
- Uncertain Future Outlook: The analyst stated that they will remain on the sidelines until there is more clarity on whether the causes of the sales slowdown are transitory or enduring, which may impact investor confidence and the stock's short-term trajectory.
See More

Company Overview: Vital Farms has made significant changes to its financial outlook, indicating a shift in strategy.
Target Price Adjustment: The target price for Vital Farms' stock has been reduced from $25 to $16, reflecting a more conservative market assessment.
See More
- Class Action Initiation: Rosen Law Firm reminds investors who purchased Vital Farms securities between May 8, 2025, and February 26, 2026, that they must apply to be lead plaintiff by May 26, 2026, to participate in the class action and potentially receive compensation without any out-of-pocket fees.
- Lawsuit Background: The lawsuit alleges that Vital Farms downplayed the risks associated with delays in rolling out its new ERP system, which led to missing its full-year 2025 earnings guidance and EPS consensus, resulting in investor losses when the truth emerged.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and recovered over $438 million for investors in 2019 alone, being ranked first in 2017 for the number of securities class action settlements, demonstrating its expertise and success in this field.
- Investor Guidance: Investors are advised to select counsel with a proven track record to represent them, avoiding firms that merely act as intermediaries, ensuring they receive the best legal support and resources during litigation.
See More
- Class Action Initiated: Wolf Haldenstein Adler Freeman & Herz LLP has announced a class action lawsuit on behalf of investors who purchased Vital Farms securities between May 8, 2025, and February 26, 2026, with a deadline of May 26, 2026, for investors to apply as lead plaintiffs, indicating significant investor dissatisfaction with the company's financial performance.
- Poor Financial Performance: Vital Farms' 10-K report filed on February 26, 2026, revealed a revenue of $759.44 million for fiscal year 2025, falling short of the $775 million guidance, while the reported earnings per share (EPS) of $0.35 also missed the market consensus of $0.39, highlighting challenges in financial management.
- ERP System Impact: The report indicated that the company faced temporary disruptions in order and fulfillment levels following the launch of a new ERP system, which may have contributed to the revenue and earnings decline, exacerbating investor concerns about operational efficiency.
- Significant Stock Price Drop: Following the earnings report, Vital Farms' stock price plummeted from $24.79 on February 25, 2026, to $22.11, representing an approximate 11% decline, reflecting a substantial decrease in market confidence regarding the company's future prospects.
See More










